DS
FBIO icon

David Shaw’s Fortress Biotech FBIO Stock Holding History

David Shaw’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-756
Closed -$17K – 3872
2019
Q2 		$17K Buy
+756
New +$19.4K ﹤0.01% 3622
2016
Q2 		– Sell
-1,325
Closed -$62K – 3376
2016
Q1 		$62K Sell
1,325
-1,398
-51% -$59K ﹤0.01% 3319
2015
Q4 		$114K Buy
+2,723
New +$114K ﹤0.01% 3658

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

David Shaw's FBIO Position: Q3 2019 in Review

David Shaw sold out of Fortress Biotech (FBIO) in Q3 2019, closing a stake of 756 shares — an estimated $17K sold.

David Shaw first reported a position in FBIO in Q4 2015 and held it in 3 quarters. The position peaked at $114K in Q4 2015. 49 funds tracked by Wall St. Rank hold FBIO as of Q3 2019.

  • David Shaw reported no remaining Fortress Biotech position as of Q3 2019 after selling out during the quarter.
  • David Shaw sold 756 Fortress Biotech shares in Q3 2019, an estimated $17K.
  • David Shaw first reported a position in Fortress Biotech in Q4 2015 and held it in 3 quarters.
  • David Shaw's Fortress Biotech position peaked at $114K in Q4 2015.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2019.

Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.